REGENERON PHARMACEUTICALS, INC. EPS (Basic) 2009-2025 | REGN
What is eps (basic)?
Basic earnings per share (EPS) can be defined as net income divided by the weighted average number of common shares outstanding during a period.
What is REGENERON PHARMACEUTICALS, INC.'s current eps (basic)?
REGENERON PHARMACEUTICALS, INC. (REGN) annual eps (basic) for 2025 was $43.07, a 5.31% increase from 2024. REGENERON PHARMACEUTICALS, INC. eps (basic) for the quarter ending September 30, 2025 was $14.09.
What was REGENERON PHARMACEUTICALS, INC.'s eps (basic) in 2024?
REGENERON PHARMACEUTICALS, INC. annual eps (basic) for 2024 was $40.90, a 10.39% increase from 2023.
What was REGENERON PHARMACEUTICALS, INC.'s eps (basic) in 2023?
REGENERON PHARMACEUTICALS, INC. annual eps (basic) for 2023 was $37.05, a 8.54% decline from 2022.
What is REGENERON PHARMACEUTICALS, INC.'s 5-year eps (basic) CAGR?
REGENERON PHARMACEUTICALS, INC. eps (basic) grew at a compound annual growth rate (CAGR) of 5.70% from FY2020 to FY2025, going from $32.65 to $43.07 over 5 years.
Year-over-year comparison from 10-K annual reports
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $43.07 | +5.3% | 10-K |
| FY2024 | $40.90 | +10.4% | 10-K |
| FY2023 | $37.05 | -8.5% | 10-K |
| FY2022 | $40.51 | -47.0% | 10-K |
| FY2021 | $76.40 | +134.0% | 10-K |
| FY2020 | $32.65 | +68.5% | 10-K |
| FY2019 | $19.38 | -14.4% | 10-K |
| FY2018 | $22.65 | +101.0% | 10-K |
| FY2017 | $11.27 | +31.8% | 10-K |
| FY2016 | $8.55 | +38.6% | 10-K |
| FY2015 | $6.17 | +83.6% | 10-K |
| FY2014 | $3.36 | -20.6% | 10-K |
| FY2013 | $4.23 | -46.6% | 10-K |
| FY2012 | $7.92 | +423.3% | 10-K |
| FY2011 | $-2.45 | -94.4% | 10-K |
| FY2010 | $-1.26 | -48.2% | 10-K |
| FY2009 | $-0.85 | - | 10-K |